Apoptosis induced by 5-flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase

Acta Pharmacologica Sinica

Volumn 21, Issue 7, 2000, Pages 655-659

  Zhang, Shi Neng ^a   Yuan, Shi Zhen ^a   Zhu, Zhao Hua ^a   Wen, Zhuo Fu ^a   Huang, Zhi Qing ^a   Zeng, Zhi Yong ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Cytosine deaminase; DNA fragmentation; Flow cytometry; Flucytosine; Fluorouracil; Gene therapy; Pancreatic neoplasms

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE;

APOPTOSIS; ARTICLE; DNA MODIFICATION; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; PANCREAS CANCER; PROTEIN EXPRESSION;

ADENOVIRUSES, HUMAN; ANTIMETABOLITES; APOPTOSIS; CYTOSINE DEAMINASE; DNA FRAGMENTATION; FLUCYTOSINE; GENE THERAPY; GENETIC ENGINEERING; HUMANS; NUCLEOSIDE DEAMINASES; PANCREATIC NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033912542     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Haycox A, Lombard M, Neoptolemos J, Walley T. Review article; current treatment and optimal patient management in pancreatic cancer. Aliment Pharmacol Ther 1998; 12: 919-61.
2. Huguier M, Mason NP. Treatment of cancer of the exocrine pancreas. Am J Surg 1999; 177: 257-65.
3. Rigg AS, Lemoine MR. Genetic prodrug activation therapy for pancreatic cancer. Ann NY Acad Sci 1999; 880: 319-25.
4. Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma cloning, sequencing and expression of Escherichia coli cytosine deaminase. Mol Pharmacol 1993; 43: 380-7.
5. Zhang LH, Zheng WD, Ling WY, Bin GU, Zhi GH, Qin LY, et al. Gene therapy for human hepatocellular carcinoma with cytosine deaminase gene and prodrug flucytosine. Acta Pharmacol Sin 1999; 20: 410-4.
6. Huber BE, Austin EA, Richards CA, Davis ST, Good SS. Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 1991; 91: 8302-6.
7. Haack K, Moebius U, Knebel Doeberitz M V, Herfarth C, Schackert HK, Gebert JF. Detection of cytosine deaminase in genetically modified tumor cells by specific antibodies. Hum Gene Ther 1997; 8: 1395-401.
8. Dole M, Nunez G, Merchant AK, Maybaum J, Rode CK, Bloch CA, et al. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1991; 54: 3253-9.
9. Evoy D, Hirschowitz EA, Naama HA, Li XK, Crystal RG, Daly JM, et al. In vivo adenoviral-mediated gene transfer in the treatment of pancreatic cancer. J Surg Res 1997; 69: 226-31.
10. Kanai F, Lan KH, Shiratori Y, Tanaka T, Ohashi M, Okudaira T, et al. In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. Cancer Res 1997; 57: 461-5.
11. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-9.
12. Haberkorn U, Oberdorfer F, Gebert J, Morr I, Haack K, Weber K, et al. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. J Nucl Med 1996; 37: 87-94.